141 related articles for article (PubMed ID: 31096186)
1. High glucose upregulates osteopontin expression by FoxO1 activation in macrophages.
Zhang Q; Wang C; Tang Y; Zhu Q; Li Y; Chen H; Bao Y; Xue S; Sun L; Tang W; Chen X; Shi Y; Qu L; Lu B; Zheng J
J Endocrinol; 2019 Aug; 242(2):51-64. PubMed ID: 31096186
[TBL] [Abstract][Full Text] [Related]
2. Repression of Transcriptional Activity of Forkhead Box O1 by Histone Deacetylase Inhibitors Ameliorates Hyperglycemia in Type 2 Diabetic Rats.
Cho HM; Seok YM; Lee HA; Song M; Kim I
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424007
[TBL] [Abstract][Full Text] [Related]
3. MiR-181c restrains nitration stress of endothelial cells in diabetic db/db mice through inhibiting the expression of FoxO1.
Yang G; Wu Y; Ye S
Biochem Biophys Res Commun; 2017 Apr; 486(1):29-35. PubMed ID: 28223216
[TBL] [Abstract][Full Text] [Related]
4. MiR-542-5p Inhibits Hyperglycemia and Hyperlipoidemia by Targeting FOXO1 in the Liver.
Tian F; Ying HM; Wang YY; Cheng BN; Chen J
Yonsei Med J; 2020 Sep; 61(9):780-788. PubMed ID: 32882762
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA MALAT1 interacts with transcription factor Foxo1 to regulate SIRT1 transcription in high glucose-induced HK-2 cells injury.
Zhou L; Xu DY; Sha WG; Shen L; Lu GY
Biochem Biophys Res Commun; 2018 Sep; 503(2):849-855. PubMed ID: 29928873
[TBL] [Abstract][Full Text] [Related]
6. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
Liu C; Zheng Y; Hu S; Liang X; Li Y; Yu Z; Liu Y; Bian Y; Man Y; Zhao S; Liu X; Liu H; Huang T; Ma J; Chen ZJ; Zhao H; Zhang Y
Metabolism; 2024 Mar; 152():155766. PubMed ID: 38145825
[TBL] [Abstract][Full Text] [Related]
7. An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice.
Ge W; Zhao Y; Yang Y; Ding Z; Xu X; Weng D; Wang S; Cheng R; Zhang J
J Biol Chem; 2021 Jul; 297(1):100846. PubMed ID: 34058194
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia.
Nilsson-Berglund LM; Zetterqvist AV; Nilsson-Ohman J; Sigvardsson M; González Bosc LV; Smith ML; Salehi A; Agardh E; Fredrikson GN; Agardh CD; Nilsson J; Wamhoff BR; Hultgårdh-Nilsson A; Gomez MF
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):218-24. PubMed ID: 19965778
[TBL] [Abstract][Full Text] [Related]
9. Resistin derived from diabetic perivascular adipose tissue up-regulates vascular expression of osteopontin via the AP-1 signalling pathway.
Park SY; Kim KH; Seo KW; Bae JU; Kim YH; Lee SJ; Lee WS; Kim CD
J Pathol; 2014 Jan; 232(1):87-97. PubMed ID: 24089355
[TBL] [Abstract][Full Text] [Related]
10. PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes.
Nakamachi T; Nomiyama T; Gizard F; Heywood EB; Jones KL; Zhao Y; Fuentes L; Takebayashi K; Aso Y; Staels B; Inukai T; Bruemmer D
Diabetes; 2007 Jun; 56(6):1662-70. PubMed ID: 17360982
[TBL] [Abstract][Full Text] [Related]
11. FOXO1 Deletion Reverses the Effect of Diabetic-Induced Impaired Fracture Healing.
Alharbi MA; Zhang C; Lu C; Milovanova TN; Yi L; Ryu JD; Jiao H; Dong G; O'Connor JP; Graves DT
Diabetes; 2018 Dec; 67(12):2682-2694. PubMed ID: 30279162
[TBL] [Abstract][Full Text] [Related]
12. Atrasentan alleviates high glucose-induced podocyte injury by the microRNA-21/forkhead box O1 axis.
Wang J; Shen L; Hong H; Li J; Wang H; Li X
Eur J Pharmacol; 2019 Jun; 852():142-150. PubMed ID: 30876973
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal Regulation of Hepatic TGF-β1 and Foxo1 Controls Gluconeogenesis and Energy Expenditure.
Pan Q; Ai W; Chen Y; Kim DM; Shen Z; Yang W; Jiang W; Sun Y; Safe S; Guo S
Diabetes; 2023 Sep; 72(9):1193-1206. PubMed ID: 37343276
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
15. Kir6.1 improves cardiac dysfunction in diabetic cardiomyopathy via the AKT-FoxO1 signalling pathway.
Wang J; Bai J; Duan P; Wang H; Li Y; Zhu Q
J Cell Mol Med; 2021 Apr; 25(8):3935-3949. PubMed ID: 33547878
[TBL] [Abstract][Full Text] [Related]
16. IL (Interleukin)-10-STAT3-Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction.
Shirakawa K; Endo J; Kataoka M; Katsumata Y; Yoshida N; Yamamoto T; Isobe S; Moriyama H; Goto S; Kitakata H; Hiraide T; Fukuda K; Sano M
Circulation; 2018 Oct; 138(18):2021-2035. PubMed ID: 29967195
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-223 is essential for maintaining functional β-cell mass during diabetes through inhibiting both FOXO1 and SOX6 pathways.
Li Y; Deng S; Peng J; Wang X; Essandoh K; Mu X; Peng T; Meng ZX; Fan GC
J Biol Chem; 2019 Jul; 294(27):10438-10448. PubMed ID: 31118273
[TBL] [Abstract][Full Text] [Related]
18. Critical role for osteopontin in diabetic nephropathy.
Nicholas SB; Liu J; Kim J; Ren Y; Collins AR; Nguyen L; Hsueh WA
Kidney Int; 2010 Apr; 77(7):588-600. PubMed ID: 20130530
[TBL] [Abstract][Full Text] [Related]
19. Diabetes Mellitus-Induced Long Noncoding RNA Dnm3os Regulates Macrophage Functions and Inflammation via Nuclear Mechanisms.
Das S; Reddy MA; Senapati P; Stapleton K; Lanting L; Wang M; Amaram V; Ganguly R; Zhang L; Devaraj S; Schones DE; Natarajan R
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1806-1820. PubMed ID: 29930005
[TBL] [Abstract][Full Text] [Related]
20. The functional -443T/C osteopontin promoter polymorphism influences osteopontin gene expression in melanoma cells via binding of c-Myb transcription factor.
Schultz J; Lorenz P; Ibrahim SM; Kundt G; Gross G; Kunz M
Mol Carcinog; 2009 Jan; 48(1):14-23. PubMed ID: 18459127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
